| | Gender | | | Female (n, %) | 39 (65.00%) | | Male (n, %) | 21 (35.00%) | | Age | | | 1–18 years (n, %) | 7 (11.66%) | | 19–40 years (n, %) | 50 (83.33%) | | >40 years (n, %) | 3 (5.01%) | | Prevalent location of the measles | | | New building of the hospital (n, %) | 60 (100%) | | Old building of the hospital (n, %) | 0 (0.00%) | | Occupation | | | Nurse (n, %) | 31 (51.66%) | | Staff (n, %) | 11 (18.33%) | | Clinical patient (n, %) | 10 (16.66%) | | Doctor (n, %) | 7 (11.66%) | | Medic (n, %) | 1 (1.69%) | | Vaccination history | | | Vaccination (n, %) | 44 (73.33%) | | Unknown (n, %) | 12 (20.00%) | | No vaccination (n, %) | 4 (6.67%) | | Positive rate of the test method | | | MV IgM (n, %) | 51 (85.00%) | | MV PCR (n, %) | 50 (83.33%) | | Both (n, %) | 41 (68.33%) | | Clinical manifestation | | | Koplik spots (n, %) | 36 (60.00%) | | Catarrh (n, %) | 51 (85.00%) | | Conjunctivitis (n, %) | 50 (83.33%) | | Complication (n, %) | | | Pneumonia (n, %) | 2 (3.33%) | | Laryngitis (n, %) | 1 (1.67%) | | Liver dysfunction (n, %) | 6 (10.00%) |
|
|
